Datasheet | January 2, 2023

Medidata Decentralized Clinical Trials (DCT) Program

Source: Medidata, a Dassault Systemes company
GettImages-1373659740 dcts

The Medidata DCT Program is a unique, innovative, and powerful technology solution to virtualize your entire clinical trial, including patient participation, data monitoring and oversight activities, and patient drug dispensation and supply management.

The Medidata DCT Program provides flexible, composable capabilities that you can adjust to optimize the level of in-person or virtual patient participation and study oversight that’s right for your trial. Patients have a better experience, and your data quality is optimized.

Using Medidata’s Trial Dial™, you can develop your protocol to support 100% site-based studies, 100% virtual studies, and everywhere in between. There is no other technology provider that supports this hybrid type of study design on a single data platform at both the patient level and the site level.

DCT Program Benefits

  • Enables Complete Decentralized Trials
  • Build Your Own Path to Decentralization
  • Data Driven Workflows on One Platform
  • Advanced Analytics Power Smarter, Safer Trials
access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Tech Leader? Subscribe today.

Subscribe to Clinical Tech Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Tech Leader